WITH the increased use of
biologics, drugs with newer
mechanisms of action and
combination therapies, the
biosimilar sector of the global
rheumatoid arthritis (RA) market is
trending strongly with a compound
annual growth rate (CAGR) of 71%
according to BCC Research.
While the global market for
therapies for RA is expected to
grow at a CAGR of 1.3%, to $17.2b
by 2020, biosimilars for major
biologic products etanercept,
infliximab and rituximab are
dominating growth.The above article was sent to subscribers in Pharmacy Daily's issue from 02 Aug 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Aug 16
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.